Fifty 1 Labs, Inc.

Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health

Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market

Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace

Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer

Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc.